# Endoclot Plus Co., Ltd.

- Location (FDA's records): Suzhou, CN
- FDA decisions: 4 (2017–2026): 4 510(k) clearances
- Product codes: PLL (2), QAU (1), GCJ (1)
- Predicates its devices cite: 7 (2 its own); citations of its devices by later devices: 3 (2 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Cosmo Technologies, Ltd.: 1 (https://510kreport.com/company/cosmo-technologies)
- Merit Medical Systems, Inc.: 1 (https://510kreport.com/company/merit-medical-systems)
- Wilson-Cook Medical, Inc.: 1 (https://510kreport.com/company/wilson-cook-medical)
- Medafor, Inc.: 1 (https://510kreport.com/company/medafor)
- Boston Scientific Corp: 1 (https://510kreport.com/company/boston-scientific)

## Firms that cite its devices most
- Hemostasis, LLC: 1 (https://510kreport.com/company/hemostasis)

## Its most-cited devices
- K191254: EndoClot (2020), cited by 1
- K190677: EndoClot (2021), cited by 1
- K162197: EndoClot (2017), cited by 1

## Recent decisions
- K260997: Sis Blu (Sisblu-30-01);Sis Blu (Sisblu-15-01) (Sep 9, 2026)
- K190677: EndoClot (Jan 29, 2021)
- K191254: EndoClot (Jan 30, 2020)
- K162197: EndoClot (Jan 18, 2017)

Source page: https://510kreport.com/company/endoclot-plus